Sign in

Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks

By Markus Hofmarcher and others
Due to the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there is an urgent need for novel therapies and drugs. We conducted a large-scale virtual screening for small molecules that are potential CoV-2 inhibitors. To this end, we utilized "ChemAI", a deep neural network trained on more than... Show more
April 3, 2020
=
0
Loading PDF…
Loading full text...
Similar articles
Loading recommendations...
=
0
x1
Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks
Click on play to start listening